Dr. Vince Clinical Research operates the ideal clinical site for Human Abuse Potential (HAP) studies. One feature of this facility is the on-site cGMP Pharmacy, built to comply with DEA standards, which is required to source the majority of reference or comparator drugs used for HAP studies.
This video is Part 4 of our Human Abuse Potential Study Series. Hear from Todd Janssen, Director, Pharmacy Operations, as he discusses DVCR’s pharmacy compliance measures, over-encapsulation in HAP studies, the importance of quality control and dosing strategies. Stay tuned for additional videos where we continue to showcase what makes DVCR the leading CRO for HAP trials.
